XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.22.2.2

SHAREHOLDERS' EQUITY | 6 Months Ended
--- | ---
Jun. 30, 2022
Stockholders' Equity Note [Abstract] |
SHAREHOLDERS' EQUITY | NOTE 8: SHAREHOLDERS' EQUITY a.Ordinary shares The ordinary shares of the Company entitle their holders to voting rights, the right to receive cash dividend and the right to a share in excess assets upon liquidation of the Company. b.Stock Options, Restricted Share Units and Warrants In 2003, the Company's Board of Directors approved the 2003 Equity Incentive Plan (the "Plan") for an initial term of ten years from adoption and on December 9, 2012, extended the term of the Plan for an additional ten years. On August 7, 2013, the Company’s Board of Directors approved amendments to the Plan which include the ability to grant RSUs and restricted shares. The contractual term of the stock options is generally no more than seven years and the vesting period of the options and RSUs granted under the Plan is between one and three years from the date of grant. The rights of the ordinary shares issued upon the exercise of stock options or RSUs are identical to those of the other ordinary shares of the Company. As of June 30, 2022, there were 235,394 ordinary shares reserved for future stock-based awards under the Plan. The following table summarizes the activities for the Company’s service-based stock options for the six months ended June 30, 2022:
|  |  |  |  | Weighted average |  |  |  |
|  | Number of options |  |  | Exercise price |  |  | Remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Outstanding at January 1, 2022 |  |  | 3,574,401 |  |  | $ | 2.46 |  |  |  | 45.90 |  |  | $ | 77,173 |
Granted |  |  | 302,514 |  |  |  | (* | ) |  |  | - |  |  |  | - |
Exercised |  |  | (739,748 | ) |  |  | 1.76 |  |  |  | - |  |  |  | 14,560 |
Cancelled |  |  | (81,087 | ) |  |  | 4.34 |  |  |  | - |  |  |  | - |
Outstanding at June 30, 2022 |  |  | 3,056,080 |  |  | $ | 2.34 |  |  |  | 47.78 |  |  | $ | 48,471 |
Exercisable at June 30, 2022 |  |  | 935,057 |  |  | $ | 5.16 |  |  |  | 3.50 |  |  | $ | 12,198 |
Vested and expected to vest at June 30, 2022 |  |  | 3,175,094 |  |  | $ | 2.36 |  |  |  | 1.57 |  |  | $ | 50,363 |
(*) Represents an amount less than $1 The following table summarizes the activities for the Company’s performance-based stock options for the six months ended June 30, 2022:
|  |  |  |  | Weighted average |  |  |  |
|  | Number of options |  |  | Exercise price |  |  | Remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Outstanding at January 1, 2022 |  |  | 903,900 |  |  | $ | 2.37 |  |  |  | 46.16 |  |  | $ | 19,599 |
Granted |  |  | 177,344 |  |  |  | (* | ) |  |  | - |  |  |  | - |
Exercised |  |  | (226,497 | ) |  |  | (* | ) |  |  | - |  |  |  | 4,929 |
Cancelled |  |  | (8,688 | ) |  |  | (* | ) |  |  | - |  |  |  | - |
Outstanding at June 30, 2022 |  |  | 846,059 |  |  | $ | 2.53 |  |  |  | 43.53 |  |  | $ | 13,241 |
Exercisable at June 30, 2022 |  |  | 300,000 |  |  | $ | 5.35 |  |  |  | 5.08 |  |  | $ | 3,849 |
Vested and expected to vest at June 30, 2022 |  |  | 830,218 |  |  | $ | 2.58 |  |  |  | 2.45 |  |  | $ | 12,953 |
(*) Represents an amount less than $1 The performance-based stock options’ vesting is contingent upon achieving specific financial targets of the Company, set at the grant date.

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration